Alpha 2.0
Login Register
» Authors » Jhoanna Roa

Jhoanna Roa

Explore the profile of Jhoanna Roa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 51
Followers 0
Related Specialties
Infectious Diseases
Pediatrics
Top 10 Co-Authors
John G McHutchison
Marion G Peters
Susanna Naggie
Kristen M Marks
Diana M Brainard
Jennifer J Kiser
Daniel S Fierer
Thomas Miller
Alexander L Greninger
Susan L Rosenkranz
Published In
Clin Infect Dis
Pediatr Infect Dis J
Affiliations
Soon will be listed here.
Recent Articles
1.
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Letendre S, Chen H, McKhann A, Roa J, Vecchio A, Daar E, et al.
Clin Infect Dis . 2023 May; 77(6):866-874. PMID: 37183889
Background: Neurocognitive impairment (NCI) in people with HIV (PWH) on antiretroviral therapy (ART) is common and may result from persistent HIV replication in the central nervous system. Methods: A5324 was...
2.
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency
Mngqibisa R, Kendall M, Dooley K, Wu X, Firnhaber C, McIlleron H, et al.
Clin Infect Dis . 2019 Sep; 71(3):517-524. PMID: 31504342
Background: Effective contraception is critical to young women with HIV-associated tuberculosis (TB), as unintended pregnancy is associated with increased perinatal morbidity and mortality. The effects of co-administration of efavirenz and...
3.
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals
Naggie S, Fierer D, Hughes M, Kim A, Luetkemeyer A, Vu V, et al.
Clin Infect Dis . 2019 Jun; 69(3):514-522. PMID: 31220220
Background: Current guidelines for the management of hepatitis C virus (HCV) infections provide varying recommendations for the optimal treatment of acute HCV infections. There are limited data from small cohort...
4.
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C
Naggie S, Marks K, Hughes M, Fierer D, MacBrayne C, Kim A, et al.
Clin Infect Dis . 2017 Mar; 64(8):1035-1042. PMID: 28329053
Background: Historically, acute hepatitis C virus (HCV) infection was treated with shorter durations of interferon-containing therapies. In the era of direct-acting antivirals (DAAs), it is unclear whether the efficacy of...
5.
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children
Siberry G, Warshaw M, Williams P, Spector S, Decker M, Jean-Philippe P, et al.
Pediatr Infect Dis J . 2011 Oct; 31(1):47-52. PMID: 21987006
Background: Human immunodeficiency virus (HIV)-infected children are at increased risk of meningococcal infection and poor response to quadrivalent meningococcal conjugate vaccine (MCV4), but MCV4 has not been studied in preadolescent...